Skip to main content
Top
Metadata
Title
An oncolytic adenovirus expressing herpes simplex virus-thymidine kinase for targeting cancer therapy: An in vitro evaluation
Authors
Fei-qun Zheng
Yin Xu
Yi-de Qin
Ren-jie Yang
Jun Han
Publication date
01-06-2009
Publisher
Chinese Anti-Cancer Association
Published in
Chinese Journal of Cancer Research / Issue 2/2009
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI
https://doi.org/10.1007/s11670-009-0090-z

Other articles of this Issue 2/2009

Chinese Journal of Cancer Research 2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine